Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Clin J Pain. 2012 Jan;28(1):39–46. doi: 10.1097/AJP.0b013e3182201a0f

Table 3. Factors associated with prevalent long-term opioid use in 1997 and 2005 in Kaiser Permanente.

1997
2005
PR (95% CI) P PR (95% CI) P
Age
  ≥50 years 0.9 (0.6, 1.4) 0.76 1.3 (0.9, 2.1) 0.20
  40-49 years 0.8 (0.6, 1.2) 0.31 1.6 (1.1, 2.4) 0.025
  18-39 years (reference) 1 1
Female 2.0 (1.3, 3.0) 0.001 1.8 (1.3, 2.5) <0.001
White Race/ethnicity 1.4 (1.0, 2.0) 0.069 1.3 (1.0, 1.7) 0.083
Years known HIV+
  ≥10 1.4 (0.9, 2.2) 0.111 1.4 (1.0, 2.1) 0.053
  5-9.9 1.1 (0.8, 1.5) 0.75 1.1 (0.7, 1.7) 0.66
  <5 (reference) 1 1
History of injection drug use 2.1 (1.5, 3.2) <0.001 1.8 (1.3, 2.6) 0.001
Prior use of antiretrovirals 1.5 (0.9, 2.5) 0.085 1.1 (0.7, 1.8) 0.62
CD4+ T-cell counts (per 100) 1.0 (0.9, 1.1) 0.70 1.0 (0.9, 1.0) 0.138
HIV virus levels (per log) 1.2 (1.0, 1.4) 0.027 1.1 (0.9, 1.3) 0.36
Prior AIDS diagnosis 2.0 (1.2, 3.1) 0.004 1.2 (0.9, 1.6) 0.250
Charlson comorbidity index2,3
  ≥2 1.9 (1.4, 2.8) <0.001
  1 1.6 (1.2, 2.1) 0.003
  0 (reference) 1.0 (1.0, 1.0) .
Prior depression diagnosis3 1.3 (1.0, 1.7) 0.058
Prior substance use disorders3 1.8 (1.3, 2.5) <0.001

PR, prevalence ratio; CI, confidence interval

1

Adjusted prevalence ratios obtained from modified Poisson regression models using Proc Genmod in SAS. Models are adjusted for all variables in table.

2

Modified Charlson comorbidity scores based on inpatient or outpatient diagnoses, excluding HIV/AIDS.

3

Prior Charlson comorbidity scores, depression diagnoses, and substance use disorders were assessed in two years prior to start of calendar year and not available for 1997.